Skip to content

Effect of Yoga on Non-alcoholic fatty Liver

Efficacy of Yoga based Lifestyle Modification (YBLM) Program vs Standard of Care on Hepatic Steatosis Indices among Adults Diagnosed with Non-alcoholic Fatty Liver Disease: A Randomized Controlled Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/11/029262
Enrollment
336
Registered
2020-11-20
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K760- Fatty (change of) liver, not elsewhere classified

Interventions

Intervention1: Yoga based Lifestyle Modification (YBLM) Program : Supervised Yoga- 30 mins daily x 5days/week x24 weeks Followed by Individualized Diet Control Intervention1: Standard Care: Moderate

Sponsors

Rakhi Mishra
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age between 25 to 50 years. Liver steatosis grade II & III diagnosed with Fibroscan (Fibrosis score F2 and F3; 7.5 to 10 kPa and 10-14 kPa respectively and Steatosis grade higher than 290 dB/m) [Memorial Sloan Kettering cancer center] BMI Overweight - 25-29.9 Obese - >= 30 Obese Type-I - 30-40 Obese Type-II - 40.1- 50 Obese Type III - >50 Medically Diagnosed with Hypertension

Exclusion criteria

Exclusion criteria: Enrolled under any other lifestyle modification program like gym, meditation Diagnosed with neurological, cardiovascular or orthopedic issues. Diagnosed with liver disease of other etiology. Practicing Regular Yoga

Design outcomes

Primary

MeasureTime frame
Anthropometric measurement: BMI, Waist circumference, Waist/Hip Ratio Surrogate Biomarkers: AST, ALT, GGT Lipid profile Triglycerides HDL-cholesterol Leptin C-reactive Protein Fasting glucose Albumin Platelets Steatosis Grade:Fibrosis score CAP score Timepoint: Pre-Interventional Baseline assessment Day 1 Post Interventional assessment- First- 12th week Second-24th week

Secondary

MeasureTime frame
To develop standardized protocol for non-alcoholic fatty liver disease Timepoint: 24th week

Countries

India

Contacts

Public ContactRakhi Mishra

AIIMS,Rishikesh

mishrarakhi92@gmail.com9513470564

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026